Eric Topol
banner
erictopol.bsky.social
Eric Topol
@erictopol.bsky.social

Eric Jeffrey Topol is an American cardiologist, scientist, and author. He is the founder and director of the Scripps Research Translational Institute, a professor of Molecular Medicine and Executive Vice-President at Scripps Research Institute, and a senior consultant at the Division of Cardiovascular Diseases at Scripps Clinic in La Jolla, California. .. more

Medicine 88%
Public Health 4%
Pinned
A new cover for SUPER AGERS after making the NYT bestseller list. Thanks to you for making it the #1 ranked new non-fiction book on Amazon.
amazon.com/gp/new-relea...

The reductionist days of "good" and "bad" cholesterol are over.
We've learned so much more about Lp(a), APOB, HDL and more
economist.com/science-and-...
as I reviewed in Super Agers tinyurl.com/3w76us9a

Now live, and thanks to @erictopol.bsky.social for organising this!
Matthew Cobb (@matthewcobb2)
This was a terrific discussion with Eric about my new biography of Francis Crick.
substack.com

The preprint in January 2025 attracted a lot of attention
x.com/EricTopol/st...

Reposted by Amir Attaran

New @pnas.org
"This work represents the most extensive study to
date regarding the effect of tattoo ink on the immune response and raises serious health concerns associated with the tattooing" including reduced response to Covid vaccination
www.pnas.org/doi/10.1073/...
Tattoo ink induces inflammation in the draining lymph node and alters the immune response to vaccination | PNAS
Despite safety concerns regarding the toxicity of tattoo ink, no studies have reported the consequences of tattooing on the immune response. In thi...
www.pnas.org

"The growing popularity of these drugs [peptides]
shows that many people will experiment with them long before science confirms they work or are safe."
www.nytimes.com/2025/11/18/w...
my review erictopol.substack.com/p/the-peptid...
The Internet Loves Peptide Therapy. Is It Really a Miracle Cure?
www.nytimes.com

Reposted by Eric J. Topol

Now out in & just in time for your long Thanksgiving drive: my annual podcast recs, from Acquired & Ground Truths @erictopol.bsky.social to Not Otherwise Specified @lisarosenbaum.bsky.social & Grand Rounds @ai.nejm.org to The Rest is History & excellence actually timmermanreport.com/2025/11/reco...
Recommended Podcasts (and A Few Books), 2025 Year-End Edition - TimmermanReport.com
It’s time for my annual feature: recommended podcasts (and a few books) for TR readers to consider. As usual, these suggestions generally steer clear of politics; they also aren’t the only podcasts I ...
timmermanreport.com

Making the diagnosis :-)

Semaglutide (Ozempic) failed to have clinical impact for slowing progression in people with mild Alzheimer’s disease in 2 large, placebo-controlled trials
novonordisk.com/content/nnco...
News Details
novonordisk.com

Reposted by Robert C. Richards

We've enrolled more than 700 participants (of 1,000 planned) in 3 weeks to a randomized trial for treatment of #LongCovid
Founder and director of the Scripps Research Translational Institute, @erictopol.bsky.social, and Julia Moore Vogel, co–principal investigator of the Long COVID Treatment Trial, were featured in @wired.com, sharing insights on a nationwide study testing GLP-1s for long COVID.
Weight-Loss Drug Zepbound Is Being Tested as a Treatment for Long Covid
GLP-1s are being studied for a wide range of conditions. Now, scientists will test whether their anti-inflammatory properties can help alleviate symptoms of long Covid.
ow.ly

How can FDA allow TV ads for GLP-1 drug microdosing without any data?
Not aware of a single published study.
youtube.com/watch?v=zIbz...
Rebel Wilson goes Micro with Noom
YouTube video by Noom
youtube.com

Reposted by Eric J. Topol